Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320918 · ClinicalTrials.gov registry record
Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
A clinical trial, sponsored by University of New Mexico.
- Terminated
- Registry status
- 10
- Enrollment target
NCT00320918: Clinical Trial study, sponsored by University of New Mexico.
NCT00320918 is a clinical trial that was terminated before completion, run by University of New Mexico. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00320918 was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
Chart Review on Patients with unresectable/metastatic cholangiocarcinoma treated in the UNM Cancer Center with a combination of irinotecan, capecitabine and celecoxib.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-11 |
| Est. Completion | 2006-10 |
Why NCT00320918 stopped before completion
NCT00320918 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00320918 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00320918 about?
NCT00320918 is a clinical study titled "Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib". Chart Review on Patients with unresectable/metastatic cholangiocarcinoma treated in the UNM Cancer Center with a combination of irinotecan, capecitabine and celecoxib.
What is the current status of trial NCT00320918?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2005-11. Estimated completion is 2006-10.
Who is sponsoring clinical trial NCT00320918?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia